Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Latest news
Common Dementia Misdiagnosis: Functional Cognitive Disorder
75% of Older Adults With Dementia May Be On the Wrong Prescriptions
‘Never Too Late:’ Brain Exercise Can Boost Cognitive Health at Any Age
Right Under Your Nose: Diagnosing Alzheimer’s in a Sneeze?
Study: Black Teens Are Exposed to More Dementia Risk Factors Than White Teens
1 in 6 Adults With Alzheimer’s Go Missing—Families on ‘Wandering’
Quadruple Misfolded Proteins May Explain Why Alzheimer’s Clinical Trials Have Failed
Pandemic Stress and Apathy: Tips for Dementia Caregivers
FDA Moves Forward on Aducanumab
Can Memory Loss Be Reversed? Experimental Drug Heads to Clinical Trials
9/11 First Responders Show Signs of Dementia
The Physical Toll of COVID-19 Is Compounded By Its Psychological Impacts
Biden, Trump, and Cognitive Decline: When Cognitive Tests Become a Campaign Issue
A Safer Dementia-Related Psychosis Treatment Grows Closer to FDA Approval
Alzheimer’s Drug Trials Have Had a 99% Failure Rate. The Good News: There Are Currently More Than 100 in the Pipeline
Previous
93
94
95
Next
Page load link
Go to Top